In July, the country’s largest trade group representing the drug industry released a report showing nearly 200 drugs under clinical development or Food and Drug Administration review for treating mental disorders.
The Florida Pharmacy Association, together with a group of Medicaid patients, independent pharmacies and pharmacists from all over Florida, filed a lawsuit Thursday in Leon County Circuit Court against the Agency for Health Care Administration to seek to restore patient access to qualified Medicaid pharmacy providers.
A new study from Harvard School of Public Health found that expanding Medicaid to low-income adults led to improved health and reduced mortality. It is the first published study to look specifically at the effect of recent state Medicaid expansions on mortality among low-income adults.
Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., on Wednesday introduced the Designer Anabolic Steroid Control Act, a bill that will protect consumers by providing the Drug Enforcement Administration with new enforcement tools to identify and quickly respond when new designer anabolic steroids are created and marketed as dietary supplements.
The Senate Committee on Commerce, Science and Transportation on Wednesday released a staff report on the investigation into the gray market for pharmaceuticals — what the committee defined as "shady operators who make enormous profits by buying hard-to-find drugs and reselling them at huge markups" — specifically naming pharmacies as a primary culprit.
The Centers for Medicare and Medicaid Services on Monday hosted a public meeting to entertain a controversial payment adjustment — called "inherent reasonableness" — in reimbursing for non-mail-order diabetes supplies.
The Centers for Disease Control and Prevention on Thursday held a press briefing regarding the growing number of whooping cough cases in Washington state, which, according to the CDC, is reflective of how pertussis cases are trending nationally.
Prescription drug abuse and diversion merit a coordinated response across federal agencies, and pending legislation can advance this unified approach, stated National Association of Chain Drug Stores president and CEO Steve Anderson in a letter to senators.
Jacques Duplessis on Monday pleaded guilty to engaging in a scheme to sell approximately 6,000 boxes of counterfeit LifeScan One Touch diabetic test strips that he purchased from suppliers in China and England, announced U.S. attorney Zane David Memeger.